Oppenheimer sees the S&P 500 climbing to 7,100 by the end of next year, vaulting past predictions from other top forecasters.

Fintel reports that on December 11, 2024, Oppenheimer downgraded their outlook for Cellectar Biosciences (NasdaqCM:CLRB) from ...

Fintel reports that on December 11, 2024, Oppenheimer downgraded their outlook for Spruce Biosciences (NasdaqCM:SPRB) from ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $380.00. The company’s ...

"I know it sounds weird for a defense lawyer to say his client was the victim, but he truly was the victim," Craig Handley's ...

Nick Dumont has spoken out publicly for the first time about “coming out to [themself] as trans,” calling it “one of the ...

While there have been “Interstellar” rereleases internationally, in China and at the Science Museum in London, Nolan saw an ...

A24 quite recently announced 70mm screenings of “The Brutalist,” which IndieWire understands have all nearly sold out rapidly ...

The South African Communist Party believes the ANC’s historic electoral defeat was due to the influence of big capital.

The hardest movie ticket to get this weekend was for a film audiences have been able to watch at home for years: Christopher ...

One such firm that believes the AI rally has even more legs to run is Goldman Sachs. In a note entitled "AI stocks aren't in a bubble" from September 2024, Goldman's Peter Oppenheimer noted that tech ...

Costco (COST) is expected to post over 7% rise in first quarter sales when it reports results on Thursday, with investors ...